Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
NCT07326930 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 173
Last updated 2026-01-08
Summary
The goal of this study is to explore the trajectory patterns of chemotherapy induced peripheral neuropathy over the course of chemotherapy and identify predictors of distinct trajectories in children with acute lymphoblastic leukemia. A perspective longitudinal study design is utilized. Chemotherapy induced peripheral neuropathy was assessed at one week after the first use of Vincristine (VCR) (T1), one week after the second use of VCR (T2), one week after the third use of VCR (T3), one week after the fourth use of VCR (T4), two weeks after T4 (T5), two weeks after T5 (T6), two weeks after T5 (T7). Patients' demographic and clinical characteristics, physical symptoms, nutrition status, psychological distress, sleep quality, physical activity, perceived social support and coping strategy are obtained at baseline.
Conditions
- Acute Lymphoblastic Leukemia ALL
Sponsors & Collaborators
-
The Hong Kong Polytechnic University
lead OTHER
Principal Investigators
-
Ka Yan Ho · The Hong Kong Polytechnic University
Eligibility
- Min Age
- 8 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-02
- Primary Completion
- 2026-01-07
- Completion
- 2026-01-07
Countries
- China
Study Locations
More Related Trials
-
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
NCT00281944 ·Status: COMPLETED ·Phase: PHASE1
-
Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00707083 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)
NCT01506453 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
NCT00002812 ·Status: COMPLETED ·Phase: PHASE3
-
N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
NCT00646230 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia
NCT00019409 ·Status: WITHDRAWN ·Phase: PHASE3
-
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
NCT00683319 ·Status: ACTIVE_NOT_RECRUITING
-
Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma
NCT00002802 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
NCT01962103 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Genetic Polymorphisms in Drug Induced Neuropathy in Children With ALL
NCT05811910 ·Status: UNKNOWN
-
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy
NCT02564484 ·Status: COMPLETED
-
Evaluation of Brain Changes in ALL Patients on Therapy
NCT04767152 ·Status: RECRUITING ·Phase: NA
-
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
NCT00369564 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
NCT00096135 ·Status: COMPLETED ·Phase: NA
-
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
NCT00017225 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
NCT00674193 ·Status: COMPLETED
-
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
NCT00613457 ·Status: COMPLETED ·Phase: PHASE3
-
N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
NCT00295919 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
NCT00006258 ·Status: COMPLETED ·Phase: PHASE2
-
Physiologic Measure of VIPN
NCT04786977 ·Status: RECRUITING
-
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00557193 ·Status: COMPLETED ·Phase: PHASE3
-
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
NCT00410631 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia
NCT06541405 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
NCT02932280 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents
NCT07168980 ·Status: RECRUITING ·Phase: PHASE2/PHASE3